期刊文献+

骨髓增生异常综合征患者单个核细胞诱导的巨噬细胞的特征及功能 被引量:1

Characteristic and function of peripheral blood mononuclear cells-induced macrophages in patients with myelodysplastic syndrome
原文传递
导出
摘要 目的观察骨髓增生异常综合征(MDS)患者单个核细胞诱导的巨噬细胞的功能,分析其与MDS疾病发展的关系。方法以2014年9月至2015年12月天津医科大学总医院血液科24例MDS患者为病例组,以15名健康志愿者为正常对照组。收集外周血标本并分离单个核细胞,体外以GM—CSF诱导分化形成巨噬细胞。在光学显微镜下观察巨噬细胞的形态;使用流式细胞术检测巨噬细胞的数量及其表面受体CD206、SIRPot的表达水平;分别采用流式细胞术和免疫荧光显微镜检测巨噬细胞的吞噬功能。结果MDS来源的巨噬细胞形态较正常对照差(形态不规则、细胞体积小、异形明显、无足突、数量减少),MDS外周血单个核细胞转化为巨噬细胞的转化率为(5.17±3.47)%,显著低于正常对照组的(66.18±13.43)%(t=3.529,P=0.001);MDS来源的巨噬细胞表面识别受体CD206的表达水平[(9.73±2.59)%]显著低于正常对照组[(51.15±10.82)%](t=-4.551,P〈0.001),SIRPa的表达水平[(0.51±0.09)%]显著低于正常对照组[(O.77±0.06)%](t=2.102,P=-0.043);@MDS来源的巨噬细胞吞噬免疫微球的吞噬指数、吞噬百分率分别为0.45±0.08、(23.69±3.22)%,显著低于正常对照组的0.92±0.07、(42.75±2.13)%(P值均〈0.05),MDS来源的巨噬细胞吞噬单个核细胞的吞噬指数(0.24±0.04)显著低于正常对照组(0.48±0.96,t=-3.464,P=0.001)。结论MDS患者外周血单个核细胞诱导形成巨噬细胞能力下降,吞噬识别受体减少,吞噬能力减弱。 Objective To explore characteristic and function of peripheral blood mononuclear cells (PBMNC)-induced macrophages in patients with myelodysplastic syndrome (MDS) to couple with its progression. Methods A total of 24 MDS patients (ll low-risk patients and 13 high-risk group patients) referred to Department of Hematology of Tianjin Medical University General Hospital and normal controls were enrolled from September 2014 to December 2015. PBMNC was stimulated with GM- CSF to transform to macrophages. The morphology of macrophages was observed by microscope. The quantity of macrophages, CD206 and SIRPct on surface of macrophages were detected by flow cytometry. The phagocytic function of macrophages was analyzed by fluorescence microscopy and flow cytometry. Results The morphology of macrophages from MDS patients was abnormal. The percentage of transformed macrophages was (5.17±3.47)% in patients with MDS, which was lower than that in controlssignificantly [ (66.18± 13.43)%, t=3.529, P=0.001 ]. The expression of CD206 on macrophages from MDS patients was significantly lower than that of controls [ (9.73±2.59)% vs (51.15± 10.82)%, t=4.551, P〈 0.001 ]. The SIRPa level of rnacrophages from MDS patients was significantly lower than that of controls [ (0.51 ±0.09)% vs (0.77±0.06)%, t=2.102, P=0.043]. The phagocytic index and the percentage of phagocytic of macrophages from MDS patients were significantly lower than those of macrophages from normal controls [ 0.45±0.08 vs 0.92±0.07, t=-6.253, P=0.008; (23.69±3.22) % vs (42.75±2.13) %, t=- 6.982, P=0.006 respectively] by flow cytometry. The phagocytic index of MDS patients was significantly lower than that of controls (0.24±0.04 vs 0.48±0.96, t=3.464, P=0.001) by fluorescence microscopy. Conclusion The quantity, recognization receptors and phagocytosis of PBMNC- induced macrophages decreased in MDS patients.
出处 《中华血液学杂志》 CAS CSCD 北大核心 2017年第8期706-709,共4页 Chinese Journal of Hematology
基金 国家自然科学基金(81170472、81400088) 天津市应用基础与前沿技术研究计划(14JCYBJC27200、09JCYBJC11200) 天津市抗癌重大专项攻关计划(12ZCDZSY17900)
关键词 骨髓增生异常综合征 巨噬细胞 Myelodysplastic syndrome Macrophage
  • 相关文献

参考文献2

二级参考文献26

  • 1邵宗鸿,陈桂彬,林泽嬉,张益枝,郝玉书,储榆林,钱林生,杨天楹,杨崇礼,冯宝章.骨髓增生异常综合征髓系细胞免疫表型及其临床意义的研究[J].中华血液学杂志,1997,18(2):80-83. 被引量:16
  • 2Jaffe ES, Harris NL, Stein H, et al. World Health Organization classification of tumours: pathology and genetics of tumours of haematopoietic and lymphoid tissue. Lyon: IARC Press,2001.61-73.
  • 3O' Connell J, Bennett MW, O' Sullivan GC, et al. The Fas counterattack: cancer as a site of immune privilege. Immunol Today, 1999,20:46-52.
  • 4Lepelley P, Grardel N, Erny O, et al. Fas/APO-1 (CD95) expression in myelodysplastic syndromes. Leuk Lymphoma, 1998,30:307-312.
  • 5Kitagawa M, Yamaguchi S, Takahashi M, et al. Localization of Fas and Fas ligand in bone marrow cells demonstrating myelodysplasia.Leukemia, 1998,12:486-492.
  • 6Paul P, Rouas-Freiss N, Khalil-Daher I,et al. HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance .Proc Natl Acad Sci U S A, 1998,95:4510-4515.
  • 7Carosella ED, Rouas-Freiss N, Paul P, et al. HLA-G: a tolerance molecule from the major histocompatibility complex. Immonol Today,1999,20:60-62.
  • 8Brouwer RE, van der Heiden P, Schreuder GM,et al. Loss or downregulation of HLA class I expression at the allelic level in acute leukemia is infrequent but functionally relevant, and can be restored by interferon. Hum Immunol,2002, 63:200-210.
  • 9Blobe GC, Schiemann WP, Lodish HF. Role of transforming growth factor β in human disease. N Eng J Med, 1999,342:1351-1358.
  • 10Norgaard P, Hougaard S, Poulsen HS, et al. Transforming growth factor β and cancer. Cancer Treat Rev,1995,21:367-403.

共引文献10

同被引文献13

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部